⌕
Arcturus Therapeutics Holdings · ARCT · Nasdaq
Tenet 61 · Solid
Compare
$8.31−0.60%At closeTenet 61 · Solid
$8.31−0.05 (−0.60%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Arcturus Therapeutics Holdings (ARCT) Stock

Arcturus Therapeutics Holdings (ARCT) closed at $8.31 on Nov 16, 2026; its Tenet Score is 61 of 100 against 417 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

Key stats

Previous close
$8.31
Nov 16, 2026
Market cap
$239.5M
share price × the latest quarter's diluted weighted-average share count (vendor)
Dividend yield
0.00%
reinvests all
Tenet Score
61/100
Solid · 417 Healthcare peers

Industry: Drugs · see every company filed here →

Arcturus Therapeutics Holdings Inc. scores 61/100. Solid. Strongest on value and financial health, quality is the soft spot versus 417 Healthcare peers.

Tenet Score · vs sector

n=417
61/ 100
Solid
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
95
Quality
22
Health
72
Growth
55

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
Momentum omitted — no data yet.
ValueAQualityFHealthBGrowthCMomentum—
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
no P/E on file
P/B
0.8×
cap ÷ fiscal 2025 book value
P/S
2.1×
price to sales
ROE
−29%
return on equity
Operating margin
−93.0%
before interest and tax
Net margin
−80.2%
of revenue kept
Current ratio
6.64
current assets to liabilities
Net debt / EBITDA
—
Withheld: this year's balance sheet carries no debt line while other years of the same company report debt, so its net debt is not known.
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
52-wk range
—
no 52-week range on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for…

Composite computed Nov 17, 2026 · peer basis: Healthcare (n=417) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 47 US ETFs · top wrappers by weightSee all ETFs holding ARCT →

What sector and industry is Arcturus Therapeutics Holdings in?

Arcturus Therapeutics Holdings is in the Healthcare sector and the Drugs industry.

What is Arcturus Therapeutics Holdings' Tenet Score?

Arcturus Therapeutics Holdings' Tenet Score is 61 out of 100, ranked against 417 Healthcare peers as of Nov 17, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.